Prime Capital Investment Advisors, LLC Inovio Pharmaceuticals, Inc. Transaction History

Prime Capital Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.52 - $13.88 $62,847 - $1.68 Million	-120,861 Reduced 92.24%	10,172 $141,000
Q4 2023 Jan 24, 2024	SELL	$0.35 - $0.53 $2,778 - $4,207	-7,939 Reduced 5.71%	131,033 $66,000
Q3 2023 Nov 09, 2023	BUY	$0.38 - $0.58 $35,962 - $54,889	94,637 Added 213.46%	138,972 $54,000
Q2 2023 Aug 08, 2023	BUY	$0.39 - $0.94 $3,717 - $8,961	9,533 Added 27.39%	44,335 $19,000
Q1 2023 May 05, 2023	BUY	$0.79 - $1.91 $27,493 - $66,471	34,802 New	34,802 $28,000
Q2 2020 Jul 17, 2020	SELL	$7.14 - $31.69 $9,339 - $41,450	-1,308 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.98 - $14.09 $3,897 - $18,429	1,308 New	1,308 $10,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $521M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.